% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schweitzer:862515,
author = {Schweitzer, Finja and Laurent, Sarah and Fink, Gereon
Rudolf and Barnett, Michael H. and Reddel, Stephen and
Hartung, Hans-Peter and Warnke, Clemens},
title = {{A}ge and the risks of high-efficacy disease modifying
drugs in multiple sclerosis},
journal = {Current opinion in neurology},
volume = {32},
number = {3},
issn = {1350-7540},
address = {[S.l.]},
publisher = {Ovid},
reportid = {FZJ-2019-02818},
pages = {305 - 312},
year = {2019},
abstract = {A variety of high-efficacy disease-modifying therapies
(DMTs) are available for the treatment of multiple sclerosis
(MS). After evaluation and approval by regulatory agencies,
DMTs are likely to be administered to patients whose
characteristics differ from those enrolled in clinical
trials. This may contribute to the emergence of unexpected
adverse events observed in the real-world setting. Higher
age may be a relevant factor that could change the
benefit–risk balance of DMTs, as it may associate with
lower efficiency and higher frequency of adverse events.},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30985373},
UT = {WOS:000480723400001},
doi = {10.1097/WCO.0000000000000701},
url = {https://juser.fz-juelich.de/record/862515},
}